​

UnitedHealth Group (UNH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

UNH Stock Forecast

UnitedHealth Group (UNH) stock forecast, based on 52 Wall Street analysts, predicts a 12-month average price target of $385.38, with a high of $444.00 and a low of $327.00. This represents a 39.10% increase from the last price of $277.05.

$250 $330 $410 $490 $570 $650 High: $444 Avg: $385.38 Low: $327 Last Closed Price: $277.05

UNH Stock Rating

UnitedHealth Group stock's rating consensus is Buy, based on 52 Wall Street analysts. The breakdown includes 1 Strong Buy (1.92%), 40 Buy (76.92%), 7 Hold (13.46%), 4 Sell (7.69%), and 0 Strong Sell (0.00%).

Buy
Total 52 4 7 40 1 Strong Sell Sell Hold Buy Strong Buy

UNH Price Target Upside V Benchmarks

TypeNameUpside
StockUnitedHealth Group39.10%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Plans Stocks30.38%

Price Target Trends

1M3M12M
# Anlaysts-1445
Avg Price Target-$384.86$386.60
Last Closing Price$277.05$277.05$277.05
Upside/Downside-38.91%39.54%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2661562-29
Feb, 2661562-29
Jan, 2661362-27
Dec, 2561262-26
Nov, 2551372-27
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 02, 2026David MacDonaldTruist Financial$370.00$287.2028.83%33.55%
Jan 30, 2026Stephen BaxterWells Fargo$370.00$292.2926.59%33.55%
Jan 30, 2026Andrew MokBarclays$327.00$292.2911.88%18.03%
Jan 28, 2026RBC Capital$361.00$291.2523.95%30.30%
Jan 28, 2026KeyBanc$405.00$288.0140.62%46.18%
Jan 28, 2026UBS$410.00$291.0040.89%47.99%
Jan 28, 2026Michael WiederhornOppenheimer$385.00$282.7036.19%38.96%
Jan 28, 2026Erin WrightMorgan Stanley$375.00$282.7032.65%35.35%
Jan 28, 2026Leerink Partners$345.00$282.7022.04%24.53%
Jan 27, 2026Piper Sandler$396.00$281.7340.56%42.93%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 30, 2026Wells FargoOverweightOverweighthold
Jan 30, 2026BarclaysOverweightOverweighthold
Jan 28, 2026KeyBancOverweightOverweighthold
Jan 28, 2026BernsteinOutperformOutperformhold
Jan 28, 2026UBSBuyBuyhold
Jan 28, 2026OppenheimerOutperformOutperformhold
Jan 27, 2026Piper SandlerOverweightOverweighthold
Jan 25, 2026Morgan StanleyOverweightOverweighthold
Jan 06, 2026BernsteinOutperformOutperformhold
Jan 06, 2026Evercore ISIOutperforminitialise

Financial Forecast

EPS Forecast

$10 $19 $28 $37 $46 $55 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$18.33$21.54$24.12$15.64$13.23----
Avg Forecast$18.84$22.02$24.96$27.61$29.72$33.50$38.08$43.85$50.63
High Forecast$19.18$22.77$25.02$27.79$30.08$34.27$39.69$44.83$51.76
Low Forecast$18.46$21.33$24.87$27.30$28.45$32.22$35.72$42.05$48.55
Surprise %-2.71%-2.18%-3.37%-43.35%-55.48%----

Revenue Forecast

$250B $340B $430B $520B $610B $700B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$287.60B$324.16B$371.62B$400.28B$447.57B----
Avg Forecast$286.74B$323.88B$369.14B$400.99B$450.84B$486.57B$522.61B$589.76B$675.82B
High Forecast$290.73B$332.33B$370.46B$402.87B$453.61B$497.97B$523.71B$599.90B$687.44B
Low Forecast$282.29B$316.03B$367.79B$400.03B$441.53B$469.85B$521.51B$571.09B$654.43B
Surprise %0.30%0.09%0.67%-0.18%-0.73%----

Net Income Forecast

$10B $18B $26B $34B $42B $50B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$17.29B$20.12B$22.38B$14.40B$12.06B----
Avg Forecast$15.70B$17.98B$22.38B$25.59B$27.19B$30.89B$35.03B$40.74B$47.04B
High Forecast$18.84B$21.58B$26.86B$25.81B$27.95B$31.83B$36.87B$41.65B$48.09B
Low Forecast$12.56B$14.39B$17.90B$25.36B$26.43B$29.94B$33.18B$39.06B$45.10B
Surprise %10.10%11.89%--43.70%-55.65%----

UNH Forecast FAQ

Is UnitedHealth Group stock a buy?

UnitedHealth Group stock has a consensus rating of Buy, based on 52 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 40 Buy, 7 Hold, 4 Sell, and 0 Strong Sell, reflecting a consensus that UnitedHealth Group is a favorable investment for most analysts.

What is UnitedHealth Group's price target?

UnitedHealth Group's price target, set by 52 Wall Street analysts, averages $385.38 over the next 12 months. The price target range spans from $327 at the low end to $444 at the high end, suggesting a potential 39.10% change from the previous closing price of $277.05.

How does UnitedHealth Group stock forecast compare to its benchmarks?

UnitedHealth Group's stock forecast shows a 39.10% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare plans stocks industry (30.38%).

What is the breakdown of analyst ratings for UnitedHealth Group over the past three months?

  • March 2026: 20.69% Strong Buy, 51.72% Buy, 20.69% Hold, 6.90% Sell, 0% Strong Sell.
  • February 2026: 20.69% Strong Buy, 51.72% Buy, 20.69% Hold, 6.90% Sell, 0% Strong Sell.
  • January 2026: 22.22% Strong Buy, 48.15% Buy, 22.22% Hold, 7.41% Sell, 0% Strong Sell.

What is UnitedHealth Group’s EPS forecast?

UnitedHealth Group's average annual EPS forecast for its fiscal year ending in December 2026 is $33.5, marking a 153.21% increase from the reported $13.23 in 2025. Estimates for the following years are $38.08 in 2027, $43.85 in 2028, and $50.63 in 2029.

What is UnitedHealth Group’s revenue forecast?

UnitedHealth Group's average annual revenue forecast for its fiscal year ending in December 2026 is $486.57B, reflecting a 8.71% increase from the reported $447.57B in 2025. The forecast for 2027 is $522.61B, followed by $589.76B for 2028, and $675.82B for 2029.

What is UnitedHealth Group’s net income forecast?

UnitedHealth Group's net income forecast for the fiscal year ending in December 2026 stands at $30.89B, representing an 156.19% increase from the reported $12.06B in 2025. Projections indicate $35.03B in 2027, $40.74B in 2028, and $47.04B in 2029.